OBJECTIVES: This study aimed to compare prognosis after segmentectomy and after lobectomy for radiologically determined solid-dominant clinical stage IA lung adenocarcinoma.
INTRODUCTION
Sublobar resection for small-sized non-small-cell lung cancer (NSCLC) has been a topic of debate for a long time [1] [2] [3] [4] [5] [6] . Ground-glass opacity (GGO)-dominant early lung adenocarcinomas are thought to be relatively benign [7] [8] [9] and can be treated with sublobar resection, including segmentectomy or wedge resection, because these tumours seldom lead to lymph node metastasis [9] . On the other hand, radiologically determined soliddominant NSCLCs show a more malignant potential, such as pathological invasiveness and lymph node metastasis, than GGO-dominant tumours [8] . Wedge resection, which cannot be used to approach hilar lymph nodes, is inappropriate as a radical procedure for a solid-dominant tumour because such a tumour might have metastasized to lymph nodes. On the other hand, segmentectomy can be used to approach hilar lymph nodes and may be applied to a solid-dominant tumour with ample surgical margin. At present, segmentectomy for a solid-dominant tumour as a radical procedure is controversial. The purpose of this study is to evaluate and compare the prognosis after segmentectomy with that after lobectomy in patients with radiologically assessed soliddominant clinical stage IA lung adenocarcinoma.
Cancer Center, Japan) between 1 August 2005, and 30 June 2010. Patients with incompletely resected tumours (R1 or R2) and those with multiple tumours or previous lung surgeries were not included in the database. The database has been maintained prospectively. The patient data obtained from this multicentre database were retrospectively analysed in the present study. High-resolution computed tomography (HRCT) and F-18-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) followed by curative R0 resection were performed for all patients staged according to the tumour, node, metastasis (TNM) Classification of Malignant Tumours, 7th Edition [10] . Neither Mediastinoscopy nor endobronchial ultrasonography was routinely performed because all patients received preoperative HRCT and FDG-PET/CT. HRCT and FDG-PET revealed an absence of >1-cm enlargement in mediastinal or hilar lymph nodes and an absence of >1.5 accumulation for maximum standardized uptake values (SUVmax) in these lymph nodes, respectively. Sublobar resection was allowed as an optional procedure for peripheral clinical T1N0M0 tumours that were intraoperatively assessed as N0 by frozen section evaluation of enlarged lymph nodes or by ensuring that there was no obvious lymph node enlargement in the thoracic cavity. Systematic lymph node dissection, such as that of hilar and mediastinal nodes, was performed during segmentectomy but not during wedge resection. All segmentectomies were performed exclusively in the patients who could tolerate lobectomy. All patients showing pathological lymph node metastasis received four cycles of platinum-based chemotherapy after surgery.
The inclusion criteria were preoperative staging determined using HRCT and FDG-PET/CT, curative surgery without neoadjuvant chemotherapy or radiotherapy and a definitive histopathological diagnosis of lung adenocarcinoma. This study was approved by 
High-resolution computed tomography
Sixteen-row multidetector CT was used to obtain chest images, independent of subsequent FDG-PET/CT examinations. For highresolution images of the tumours, the following parameters were used: 120 kVp, 200 mA, 1-2 mm section thickness, 512 × 512 pixel resolution, 0.5-1.0 s scanning time, a high-spatial reconstruction algorithm with a 20-cm field of view (FOV), and mediastinal (level, 40 HU; width, 400 HU) and lung (level, −600 HU; width, 1600 HU) window settings. GGO was defined as a misty increase in lung attenuation without obscuring the underlying vascular markings. Radiologically determined solid-dominant tumour was defined as a tumour with ≥50% solid component. Solid tumour size was defined as the maximum dimension of the solid component measured on lung window settings, excluding GGO [11] . Mixed GGO tumour was defined as a tumour that had both GGO and solid component. CT scans were reviewed and tumour sizes were determined by radiologists from each institution.
F-18-fluorodeoxyglucose positron emission tomography/computed tomography
The patients were instructed to fast for at least 4 h before intravenous injection of 74-370 MBq of FDG and were then advised to rest for at least 1 h before FDG-PET/CT scanning. Blood glucose levels were calculated before the tracer injection to confirm a level of <150 mg/dl [12] . Patients with blood glucose levels ≥150 mg/dl were excluded from the PET/CT imaging. For imaging, Discovery ST (GE Healthcare, Little Chalfont, UK), Aquiduo (Toshiba Medical Systems Corporation, Tochigi, Japan) or Biograph Sensation16 (Siemens Healthcare, Erlangen, Germany) integrated threedimensional PET/CT scanner were used. Low-dose non-enhanced CT images of 2-4 mm section thickness for attenuation correction and localization of lesions identified by PET were obtained from the head to the pelvic floor of each patient according to a standard protocol.
Immediately after CT, PET was performed with the identical axial FOV for 2-4 min/table position, depending on the condition of the patient and the scanner performance. An iterative algorithm with CT-derived attenuation correction was used to reconstruct all PET images with a 50-cm FOV. An anthropomorphic body phantom (NEMA NU2-2001, Data Spectrum Corp, Hillsborough, NC, USA) was used to minimize the variations in SUVs among the institutions [13] . A calibration factor was derived by dividing the actual SUV by the gauged mean SUV in the phantom background to decrease interinstitutional SUV inconsistencies. The final SUV used in this study is referred to as the revised SUVmax [14] . The original SUVmax values were determined by radiologists from each institution.
Follow-up evaluation
All patients who underwent lung resection were followed up from the day of surgery. Postoperative follow-up procedures, including a physical examination, chest roentgenogram every 3 months and chest and abdominal CT examinations every 6 months, were performed for the first 2 years. Subsequently, a physical examination and chest roentgenogram were performed every 6 months, and a chest CT examination was performed every year.
Statistical analysis
Results are given as numbers (%) or medians, unless stated otherwise. A χ 2 test was used to compare categorical variable frequencies. Fisher's exact test was used when sample sizes were small. Mann-Whitney U-test was used to compare continuous variables. Recurrence-free survival (RFS) was defined as the time from the date of surgery until the first event (relapse or death due to any cause) or the last follow-up. The Kaplan-Meier method was used to assess RFS durations and these were compared using log-rank tests. To assess the potential independent effects of the surgical procedure on RFS, we used multivariate analyses with a Cox proportional hazards model. The SPSS software (version 10.5; SPSS, Inc., Chicago, IL, USA) was used for statistical analysis. Level of significance was set at a P-value of <0.05.
RESULTS
Of the 610 patients, 371 had radiologically determined soliddominant tumours that had ≥50% solid component on HRCT analysis. Of these, 327 patients underwent lobectomy or segmentectomy and were analysed in this study (Fig. 1) . No 30-day postoperative mortality was observed for the study subjects. The mean follow-up period after lobectomy and segmentectomy were 42.2 ± 16.4 months and 42.0 ± 19.2 months, respectively (P = 0.79).
The characteristics of the 327 patients are given in Table 1 . Of these, 286 patients underwent lobectomy and 41 patients underwent segmentectomy. Lobectomy was performed significantly more often for patients with large whole and solid tumour size and high SUVmax tumours of clinical factors, and as a result, for those with vascular invasion and higher pathological stage. Details of procedures in segmentectomy are given in Table 2 . One patient who underwent right S6 segmentectomy had lymph node involvement in Station 7. He developed multiple lung metastases 19.2 months after the operation. He has been receiving gefitinib and is alive and well without disease 43.3 months after the operation.
When comparing mixed GGO tumours with pure solid tumours, preoperative solid tumour size and SUVmax were significantly larger and carcinoembryonic antigen (CEA) was significantly higher in pure solid tumours. Regarding pathological factors, lymphatic invasion, vascular invasion, pleural invasion and lymph node metastasis were significantly more frequent in pure solid tumours (Table 3) .
There was no significant difference in RFS between patients with a solid-dominant tumour who underwent lobectomy and those who underwent segmentectomy (3-year RFS, 84.4 vs 84.8%, respectively; P = 0.69, Fig. 2A ). In patients with a mixed GGO tumour, there was no difference in RFS between patients who underwent lobectomy and those who underwent segmentectomy (3-year RFS, 91.0 vs 85.0%, respectively; P = 0.60, Fig. 2B ). Even in patients with pure solid tumours, no significant difference in RFS was observed between the lobectomy and segmentectomy groups (3-year RFS, 76.8 vs 84.7%, respectively; P = 0.48, Fig. 2C ). Univariate and multivariate analyses of RFS are given in Table 4 . Multivariate analysis, including variables such as age, gender, solid tumour size on HRCT, SUVmax on FDG-PET/CT, tumour type, CEA and the surgical procedure, revealed that solid tumour size and SUVmax were independent prognostic factors for RFS (P = 0.048 and P < 0.001, respectively, Table 4 ). Table 5 shows postoperative recurrence patterns between the patients who underwent lobectomy and those who underwent segmentectomy. No significant difference in local and distant recurrence rate was observed between the lobectomy and the segmentectomy groups (local, 5.6 vs 7.3%, P = 0.72; distant, 9.1 vs 4.9%, P = 0.55, respectively).
DISCUSSION
In previous studies, GGO-dominant tumours were reported to be relatively benign tumours, which rarely have pathological invasiveness and lymph node metastasis, and are therefore suitable for sublobar resection such as wedge resection and segmentectomy [9] . On the other hand, radiologically determined solid-dominant tumours have a higher chance to exhibit pathological invasion such as lymphatic, vascular or pleural invasion and lymph node metastasis [8] . Indeed, about 20% of solid-dominant tumours had lymph node metastasis in this study. The prognostic significance of segmentectomy in such more malignant tumours is currently not well known. In the current study, the RFS of patients with soliddominant tumour who underwent segmentectomy was similar to (no significant difference) that of those who underwent lobectomy.
Among radiologically determined solid-dominant tumours, pure solid tumours had a higher malignant potential than mixed tumours with GGO [15] [16] [17] . The present study also showed that pure solid tumours, which had a larger solid tumour size and SUVmax, exhibited more pathological invasiveness and lymph node metastasis than mixed tumours. However, in pure solid tumours as well as mixed tumours, there was no significant difference in RFS between patients who underwent lobectomy and those who underwent segmentectomy. Interestingly, multivariate Cox proportional hazard model revealed that only solid tumour size on HRCT and SUVmax on FDG-PET/CT, and not tumour type ( pure solid or mixed tumour) and the surgical procedure, were independent prognostic factors for RFS. In early lung adenocarcinoma, tumour types on HRCT are often classified as pure GGO, mixed GGO and pure solid tumour according to the GGO ratio, and these classifications represent their pathological malignancies well [16] [17] [18] . Actually, we reported that GGO-dominant lung adenocarcinoma rarely exhibited pathological invasiveness or lymph node metastasis regardless of solid tumour size and SUVmax [9] . However, in solid-dominant lung adenocarcinoma, solid tumour size on HRCT and SUVmax on FDG-PET/CT, rather than the presence of a GGO component, represent pathological malignancies. Solid tumour size on HRCT and SUVmax on FDG-PET/CT are important preoperative factors for early lung adenocarcinoma to predict pathological invasiveness, lymph node status and prognosis [11, [19] [20] [21] . In addition, the present study suggests that the RFS of segmentectomy is similar to that of lobectomy, even in more malignant populations such as those with large solid tumour sizes and high SUVmax. When we apply segmentectomy to early lung cancers, we must avoid any recurrence in the residual pulmonary segments as much as possible. Although the recurrence patterns between lobectomy and segmentectomy groups were not significantly different, we experienced two recurrences in the residual segments after segmentectomy. Fortunately, those patients were treated with completion lobectomy and are alive and well without disease for 31 and 72 months after the initial operation. Because solid tumour size on HRCT and SUVmax on FDG-PET/CT were reported as independent prognostic factors for local RFS [6] , patients with tumours with a large solid tumour size or a high SUVmax should carefully be chosen for segmentectomy. Taking wide surgical margins and intraoperative lymph node examinations using frozen sections are mandatory for such risky cases. When taking wide margins is difficult or lymph node metastasis is detected intraoperatively, the procedure should be converted to a lobectomy.
Because this was a retrospective study, patient selection for segmentectomy may have been very strict. Far degree of selection bias might lead to the results of this study, shown in baseline characteristics of patients (Table 1) between the lobectomy and segmentectomy groups. Also, to definitely conclude that segmentectomy does not worsen the prognosis when compared with lobectomy is difficult since the follow-up period is relatively short. We are eagerly awaiting the results of the large phase III trials, CALGB140503 in the USA and JCOG0802/WJOG4607L in Japan [22] .
In conclusion, segmentectomy for solid-dominant clinical stage IA lung adenocarcinoma showed RFS equivalent to that of standard lobectomy in our selected patients. Segmentectomy can be performed even for a pure solid tumour under strict intraoperative lymph node examination. The prognosis of patients with a solid-dominant tumour depends on the solid tumour size on HRCT and SUVmax on FDG-PET/CT, rather than the surgical procedure. 
